Explore the MFN proposal to lower prescription drug costs while ensuring healthcare innovation and leadership in America.

Explore key strategies for reducing U.S. healthcare costs and improving insurance participation. Learn about proposed reforms and bipartisan cooperation in healthcare.

UCB's $2B investment in Atlanta and Florida's HIV medication expansion highlight key health industry trends. Explore the impacts and implications for healthcare.

Explore public concerns about prescription drug costs, the impact of TrumpRx, and the necessity for stronger regulations to ensure affordability for all.

Discover how the Inflation Reduction Act benefits Medicare Part D by reducing prescription costs and improving health outcomes for beneficiaries.

Eli Lilly's weight-loss drug plans face challenges with Medicare's $50 cap on out-of-pocket costs, impacting insurance regulations.

Explore the critique of Trump’s healthcare policies and their impact on insurance costs and access. Understand the implications for families and consumers.

The Supreme Court's rulings and CMS drug price negotiations may impact insurance compliance. Explore regulations affecting the insurance industry today.

Explore AHA's response to the CMS's proposed drug pricing model aiming to lower costs under Medicare Part B while addressing hospital concerns.

Explore the implications of the Trump Administration's MFN pricing and CMS's GLOBE and GUARD models on Medicare and pharmaceutical manufacturers. Act now!